A diabetes-associated peptide in the glutamic acid decarboxylase 65 (GAD65) molecule, p524-543, activates two distinct populations of T cells, which apparently play opposite roles in the development of diabetes in NOD mice. By comparing the fine specificity of these two T cell repertoires using a nested set of truncated peptides that cover the p524-543 region, we found, surprisingly, that all clones recognized the same core within this peptide, p530-539. The core itself was non-immunogenic, but the residues flanking this shared sequence played the crucial role in selecting T cells to activate. A peptide missing N-terminal flanking residues at position 528 and 529 was stimulatory in NOD but not in MHC-matched, NODresistant (NOR) mice, suggesting that a protective response in the resistant mice may require T cell recognition of one or more of the N-terminal flanking residues. T cell repertoire studies demonstrated selective clonal expansions within the BV4 TCR family that dominates the p524-543 response in NOD but not in NOR mice. These data suggest that processing or trimming events affecting T cell recognition of very few flanking residues of diabetes-associated determinants might be involved in the protective response in NOR mice.Key words: Antigens/peptides/epitopes Ă Autoimmune Ă GAD65 Ă T cell repertoire
IntroductionProcessing and presentation of islet antigens on I-A g7 molecules is a crucial aspect in the emergence of spontaneous type 1 diabetes (T1D) in NOD mice. How the peptide-binding motif of I-A g7 relates to the selection and processing of peptide determinants and subsequent repertoire choice in this mouse strain and its related strains remains unresolved. Several autoantigens have been defined in type 1 diabetes (T1D) using antigen-specific antibody and/or T cell assays, including glutamic acid decarboxylase 65 (GAD65), proinsulin and insulin, insulinoma-like antigen 2 (IA-2), and insulin-specific glucose-6-phosphatase catalytic subunitrelated protein (IGRP). In NOD mice, several peptides from these autoantigens have been identified as targets of T cell responses. These include GAD65 p524-543 and p246-266 [1, 2], GAD65 p206-220 and p286-300 [3], insulin B chain p9-23 [4,5], proinsulin p24-33 (proinsulin II p48-57) [6],, and insulin-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) p206-214 [8]. Extensive analysis of TCR BV gene usage and CDR3 sequences have demonstrated that the early islet-infiltrating T cell clonal expansion is restricted to distinct BV families, e.g., BV4 [9], BV2, BV12, BV14 [10], BV13 [11], BV8.2 [12], and BV1 [13]. This indicates that selective clonal expansion of antigen-specific T cells is one characteristic of the initial inflammatory response in the islets. A recombinant congenic strain, which is NOD-resistant (NOR) and derives *88% of its genome from the NOD strain, including the I-A g7 MHC haplotype, was produced adventitiously at the Jackson Laboratory [14], and can be used as a control strain, since NOR mice are insulitis resistant and diabetes ...